Bao Qiao - Zhongzhu Medical VP Director
| 600568 Stock | 1.36 0.02 1.49% |
Director
Bao Qiao is VP Director of Zhongzhu Medical Holdings
| Age | 56 |
| Address | Yanlord Binhai Center, Zhuhai, China, 519020 |
| Phone | 86 72 8640 2068 |
| Web | https://www.zz600568.com |
Zhongzhu Medical Management Efficiency
The company has return on total asset (ROA) of (0.0708) % which means that it has lost $0.0708 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0706) %, meaning that it generated substantial loss on money invested by shareholders. Zhongzhu Medical's management efficiency ratios could be used to measure how well Zhongzhu Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Zhongzhu Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 64.2 M, whereas Other Current Assets are forecasted to decline to about 30.8 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Yuan Gong | Sichuan Chuantou Energy | 46 | |
| Lin Luan | Kuang Chi Technologies | 45 | |
| An Gu | Chongqing Road Bridge | 66 | |
| Kai Liao | Changsha Jingjia Microelectroni | 43 | |
| Lin Jia | Chongqing Road Bridge | 37 | |
| Ge Zhang | Loongson Technology Corp | 41 | |
| Xiaodong Yang | Empyrean Technology Co | 52 | |
| Shao Liu | Cambricon Technologies Corp | 37 | |
| Hao Liu | Sichuan Chuantou Energy | 47 | |
| Zhiya Zhao | Kuang Chi Technologies | 48 | |
| Xiang Gao | Loongson Technology Corp | 42 | |
| Yajun Li | Chongqing Road Bridge | 60 | |
| Lijun Zhang | Shenzhen Fortune Trend | 46 | |
| Qing Huang | Shenzhen Fortune Trend | 62 | |
| Sheng Yu | Changsha Jingjia Microelectroni | 52 | |
Management Performance
| Return On Equity | -0.0706 | ||||
| Return On Asset | -0.0708 |
Zhongzhu Medical Holdings Leadership Team
Elected by the shareholders, the Zhongzhu Medical's board of directors comprises two types of representatives: Zhongzhu Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zhongzhu. The board's role is to monitor Zhongzhu Medical's management team and ensure that shareholders' interests are well served. Zhongzhu Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zhongzhu Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zhongzhu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zhongzhu Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0706 | ||||
| Return On Asset | -0.0708 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.25) % | ||||
| Current Valuation | 2.34 B | ||||
| Shares Outstanding | 1.99 B | ||||
| Shares Owned By Insiders | 57.85 % | ||||
| Price To Book | 1.19 X | ||||
| Price To Sales | 4.22 X | ||||
| Revenue | 638.56 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Zhongzhu Stock
Zhongzhu Medical financial ratios help investors to determine whether Zhongzhu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhongzhu with respect to the benefits of owning Zhongzhu Medical security.